Canada markets open in 1 hour 14 minutes

Applied Therapeutics, Inc. (APLT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.3300+0.1600 (+5.05%)
At close: 04:00PM EST
3.1100 -0.22 (-6.61%)
Pre-Market: 08:09AM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 256.65M
Enterprise Value 151.26M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.96
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.49

Trading Information

Stock Price History

Beta (5Y Monthly) 0.90
52-Week Change 3-83.80%
S&P500 52-Week Change 314.56%
52 Week High 329.8000
52 Week Low 32.8700
50-Day Moving Average 38.7839
200-Day Moving Average 315.4889

Share Statistics

Avg Vol (3 month) 3275.13k
Avg Vol (10 day) 3246.01k
Shares Outstanding 526.22M
Implied Shares Outstanding 6N/A
Float 812.74M
% Held by Insiders 121.42%
% Held by Institutions 178.43%
Shares Short (Dec. 30, 2021) 41.06M
Short Ratio (Dec. 30, 2021) 49.61
Short % of Float (Dec. 30, 2021) 45.98%
Short % of Shares Outstanding (Dec. 30, 2021) 44.05%
Shares Short (prior month Nov. 29, 2021) 41.02M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-52.52%
Return on Equity (ttm)-107.69%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-102.11M
Diluted EPS (ttm)-4.1350
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)108.8M
Total Cash Per Share (mrq)4.15
Total Debt (mrq)3.41M
Total Debt/Equity (mrq)3.94
Current Ratio (mrq)3.79
Book Value Per Share (mrq)3.31

Cash Flow Statement

Operating Cash Flow (ttm)-86.54M
Levered Free Cash Flow (ttm)-43.92M